CN113275584A - Micro-nano silver powder and preparation method and application thereof - Google Patents
Micro-nano silver powder and preparation method and application thereof Download PDFInfo
- Publication number
- CN113275584A CN113275584A CN202110549513.8A CN202110549513A CN113275584A CN 113275584 A CN113275584 A CN 113275584A CN 202110549513 A CN202110549513 A CN 202110549513A CN 113275584 A CN113275584 A CN 113275584A
- Authority
- CN
- China
- Prior art keywords
- micro
- silver powder
- nano silver
- preparation
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 90
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- 108010043958 Peptoids Proteins 0.000 claims abstract description 34
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 20
- -1 beta-hydroxybutyryl-amino Chemical group 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000001914 filtration Methods 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 30
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 26
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000010248 power generation Methods 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 claims description 4
- 229910000367 silver sulfate Inorganic materials 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 3
- 229920001184 polypeptide Chemical group 0.000 claims description 3
- 108090000765 processed proteins & peptides Chemical group 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 238000006068 polycondensation reaction Methods 0.000 claims description 2
- 150000001371 alpha-amino acids Chemical group 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 claims 1
- 239000002270 dispersing agent Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000011259 mixed solution Substances 0.000 description 12
- KGJXFVOAIVSRGU-MQWKRIRWSA-N CC(O)CC(=O)N[C@@H](CCCCN)C(O)=O Chemical compound CC(O)CC(=O)N[C@@H](CCCCN)C(O)=O KGJXFVOAIVSRGU-MQWKRIRWSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 108010016626 Dipeptides Proteins 0.000 description 6
- 150000001370 alpha-amino acid derivatives Chemical group 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000012876 topography Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 3
- NMYQKDXBZKTRLS-AGROOBSYSA-N (2S)-2-[[(2S)-2-[[2-(3-hydroxybutanoylamino)acetyl]amino]propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound OC(CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)C NMYQKDXBZKTRLS-AGROOBSYSA-N 0.000 description 3
- LQXLODGQLFQLAW-GDVGLLTNSA-N (2s)-2-(3-hydroxybutanoylamino)pentanedioic acid Chemical compound CC(O)CC(=O)N[C@H](C(O)=O)CCC(O)=O LQXLODGQLFQLAW-GDVGLLTNSA-N 0.000 description 3
- FELSNFUBVBSUPL-UZPQQBEXSA-N CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O Chemical compound CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O FELSNFUBVBSUPL-UZPQQBEXSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- BQFLYHMTMWHCMF-VWMHFEHESA-N N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C Chemical compound N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C BQFLYHMTMWHCMF-VWMHFEHESA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 3
- SYQNQPHXKWWZFS-YFKPBYRVSA-N (4s)-4-amino-5-ethoxy-5-oxopentanoic acid Chemical compound CCOC(=O)[C@@H](N)CCC(O)=O SYQNQPHXKWWZFS-YFKPBYRVSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- KPWCQEUBJAIORR-RGMNGODLSA-N ethyl (2s)-2-amino-4-methylsulfanylbutanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CCSC KPWCQEUBJAIORR-RGMNGODLSA-N 0.000 description 2
- 238000012643 polycondensation polymerization Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000004841 bisphenol A epoxy resin Substances 0.000 description 1
- 239000004842 bisphenol F epoxy resin Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- SGEJVUZMEHMANQ-FJXQXJEOSA-N ethyl (2s)-2,6-diaminohexanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CCCCN SGEJVUZMEHMANQ-FJXQXJEOSA-N 0.000 description 1
- PQGVTLQEKCJXKF-RGMNGODLSA-N ethyl (2s)-2-amino-3-methylbutanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)C(C)C PQGVTLQEKCJXKF-RGMNGODLSA-N 0.000 description 1
- JCXLZWMDXJFOOI-WCCKRBBISA-N ethyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@H](C)N JCXLZWMDXJFOOI-WCCKRBBISA-N 0.000 description 1
- QQGRWNMNWONMOO-LEUCUCNGSA-N ethyl (2s,3s)-2-amino-3-methylpentanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)[C@@H](C)CC QQGRWNMNWONMOO-LEUCUCNGSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- SDLBJIZEEMKQKY-UHFFFAOYSA-M silver chlorate Chemical compound [Ag+].[O-]Cl(=O)=O SDLBJIZEEMKQKY-UHFFFAOYSA-M 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B1/00—Conductors or conductive bodies characterised by the conductive materials; Selection of materials as conductors
- H01B1/20—Conductive material dispersed in non-conductive organic material
- H01B1/22—Conductive material dispersed in non-conductive organic material the conductive material comprising metals or alloys
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
Abstract
The invention provides micro-nano silver powder and a preparation method and application thereof, wherein the preparation method of the micro-nano silver powder comprises the following steps: dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder; the peptoid compound is a beta-hydroxybutyryl-amino acid compound. According to the preparation method of the micro-nano silver powder, the peptoid compounds are used as the dispersing agents, so that the micro-nano silver powder can be prepared, the appearance, the granularity and the structure of the micro-nano silver powder can be adjusted by adopting the peptoid compounds with different chemical structures, and the structure and the appearance of the micro-nano silver powder can be controlled. The micro-nano silver powder prepared by the method has good dispersibility, smaller specific surface area and resistivity than those of a commercially available sample, and good performance.
Description
Technical Field
The invention relates to the technical field of nano materials, in particular to micro-nano silver powder and a preparation method and application thereof.
Background
The nano and micron metal silver powder material is widely applied in the fields of electronic ceramics, solar photovoltaic power generation, sterilization, disinfection, electronic flexible printing and the like. The morphology and structure of the micro-nano silver powder prepared by the existing method cannot be well controlled, and the structure and morphology of the silver powder are directly related to the quality and performance of the prepared silver powder. Therefore, a preparation method capable of better controlling the structure and morphology of the micro-nano silver powder is needed.
Disclosure of Invention
In view of the above, the invention provides micro-nano silver powder and a preparation method thereof, so as to solve or partially solve the technical problems in the prior art.
In a first aspect, the invention provides a preparation method of micro-nano silver powder, which comprises the following steps:
dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder;
wherein the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R)nis alpha-amino acid substituent or polypeptide chain formed by alpha-amino acid condensation polymerization.
Preferably, in the method for preparing the micro-nano silver powder, the silver salt comprises at least one of silver nitrate, silver sulfate and silver halide.
Preferably, in the preparation method of the micro-nano silver powder, the solvent comprises one of water, methanol, ethanol, glycol, glycerol and acetone.
Preferably, in the preparation method of the micro-nano silver powder, the reducing agent comprises at least one of glucose, formaldehyde, formic acid, ethylene glycol, sodium borohydride and ascorbic acid.
Preferably, the preparation method of the micro-nano silver powder comprises the steps of dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering to obtain the micro-nano silver powder, wherein the reaction temperature is 80-220 ℃, and the reaction time is 180-720 min.
Preferably, in the preparation method of the micro-nano silver powder, the mass-to-volume ratio of the peptoid compound, the silver salt, the reducing agent and the solvent is (0.5-10) g: (0.5-15) g: (0.5-18) g: (30-80) ml.
In a second aspect, the invention also provides micro-nano silver powder prepared by the preparation method.
In a third aspect, the invention also provides application of the micro-nano silver powder in preparation of conductive silver paste, electronic ceramics, sterilization disinfectors and solar photovoltaic power generation devices.
Compared with the prior art, the micro-nano silver powder and the preparation method and application thereof have the following beneficial effects:
(1) according to the preparation method of the micro-nano silver powder, the peptoid compounds are used as the dispersing agents, so that the micro-nano silver powder can be prepared, the appearance, the granularity and the structure of the micro-nano silver powder can be adjusted by adopting the peptoid compounds with different chemical structures, and the structure and the appearance of the micro-nano silver powder can be controlled.
(2) The micro-nano silver powder prepared by the method has good dispersibility, smaller specific surface area and resistivity than those of a commercially available sample, and good performance; the conductive silver paste prepared from the micro-nano silver powder has better performance than the conductive silver paste prepared from the existing silver powder.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. It is obvious that the drawings in the following description are only some embodiments of the invention, and that for a person skilled in the art, other drawings can be derived from them without inventive effort.
FIG. 1 is a surface topography of the micro-nano silver powder prepared in embodiment 1 of the invention;
FIG. 2 is a surface topography of the micro-nano silver powder prepared in embodiment 2 of the invention;
FIG. 3 is a surface topography of the micro-nano silver powder prepared in embodiment 3 of the invention;
FIG. 4 is a surface topography of the micro-nano silver powder prepared in embodiment 4 of the invention;
FIG. 5 is a surface topography of the micro-nano silver powder prepared in embodiment 5 of the invention;
fig. 6 is a surface topography of the micro-nano silver powder prepared in embodiment 6 of the invention.
Detailed Description
In the following, the technical solutions in the embodiments of the present invention will be clearly and completely described in conjunction with the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder;
wherein, the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R)nis alpha-amino acid substituent or polypeptide chain formed by alpha-amino acid condensation polymerization.
It should be noted that, in the embodiment of the present application, the peptoid compound is used as a dispersant to implement preparation of the micro-nano silver powder, and specifically, the peptoid compound is a β -hydroxybutyryl-amino acid compound, and a structural formula of the peptoid compound is as follows:the shape, granularity and structure of the micro-nano silver powder can be adjusted by adopting different (R) n groups, so that the structure and shape of the micro-nano silver powder can be controlled.
Specifically, in some embodiments, the α -amino acid can be alanine, arginine, aspartic acid, cysteine, glutamine, glutamic acid, histidine, isoleucine, glycine, asparagine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, or the like, corresponding (R)nPolypeptide chain formed by the alpha-amino acid through polycondensation.
In particular, in some embodiments, the β -hydroxybutyryl-amino acid compound may be in particular:
the specific structure of the beta-hydroxybutyryl-amino acid compound and the synthesis method thereof all adopt the prior art, and the application does not improve the structure.
In some embodiments, the silver salt is a soluble or low-soluble silver salt, specifically, the silver salt comprises at least one of silver nitrate, silver sulfate, and silver halide.
In some embodiments, the solvent is water or an organic alcohol or ketone with a molecular weight of less than 300, and the specific solvent may be one of methanol, ethanol, ethylene glycol, glycerol and acetone.
In some embodiments, the reducing agent comprises at least one of glucose, formaldehyde, formic acid, ethylene glycol, sodium borohydride, and ascorbic acid.
In some embodiments, the peptoid compound is dissolved in a solvent, silver salt and a reducing agent are added, after reaction, the micro-nano silver powder is obtained by filtering, wherein the reaction temperature is 80-220 ℃, and the reaction time is 180-720 min.
In some embodiments, the peptoid compound is dissolved in a solvent, silver salt and a reducing agent are added, after reaction, filtration is carried out, then the filtrate is cleaned by ethanol and deionized water, organic matters and impurity salts on the surface of the filtrate are removed, and the micro-nano silver powder is obtained
In some embodiments, the mass to volume ratio of the peptoid compound, the silver salt, the reducing agent, and the solvent is (0.5-10) g: (0.5-15) g: (0.5-18) g: (30-80) ml.
Based on the same inventive concept, the invention also provides micro-nano silver powder prepared by the preparation method.
Based on the same invention concept, the invention also provides application of the prepared micro-nano silver powder in preparation of conductive silver paste, electronic ceramics, sterilization disinfectors and solar photovoltaic power generation devices.
The following further describes a preparation method of the micro-nano silver powder according to the present application with specific examples.
Example 1
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 1.8g of silver nitrate and 1.6g of peptoid compound into 60mL of ethanol, adding 2g of reducing agent ascorbic acid, and stirring for 30min to uniformly mix the solution to obtain a mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 120 ℃, keeping the temperature for 720 minutes at a constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder.
Wherein, the peptoid compound is beta-hydroxybutyryl-lysine pseudo dipeptide, and the structural formula is as follows:
specifically, the preparation method of the beta-hydroxybutyryl-lysine pseudo dipeptide comprises the following steps:
s1, adding 0.01mol of tert-butyl dimethyl silyl ether beta-hydroxybutyric acid, 0.01mol of lysine ethyl ester hydrochloride and 0.001mol of 4-dimethylamino pyridine into 50ml of dichloromethane, stirring, then adding 0.024mol of triethylamine, and stirring to react for 20min to obtain a reaction solution;
s2, dissolving 0.015mol of N, N' -dicyclohexylcarbodiimide in 20mL of dichloromethane, then dripping the reaction solution into the dichloromethane, stirring the solution at room temperature for 3 hours after dripping is finished, carrying out suction filtration, washing the filtrate with 50mL of water twice, washing the filtrate with 20mL of 0.1M dilute hydrochloric acid twice, washing the filtrate with 20mL of saturated sodium bicarbonate aqueous solution once, washing the filtrate with 20mL of saturated sodium chloride aqueous solution once, drying the dichloromethane phase and then concentrating;
s3, dissolving the condensed concentrated solution with 50mL of tetrahydrofuran, adding 1 equivalent of tetrabutyl ammonium fluoride, stirring for 1h at room temperature, then adding water for quenching reaction, evaporating the tetrahydrofuran under reduced pressure, extracting the water phase with 30mL of dichloromethane for 3 times respectively, combining organic phases, washing with 30mL of saturated sodium chloride once, concentrating, adding 1 equivalent of 1M sodium hydroxide aqueous solution into the concentrated solution, keeping the pH value at 7-8, stirring for 1h, washing the reaction solution with 20mL of dichloromethane for three times, concentrating the water phase, recrystallizing with ethanol/acetone to obtain 1.5g of white solid, namely beta-hydroxybutyryl-lysine pseudo-dipeptide sodium salt, obtaining the yield of 62.5%, adding an equivalent of hydrogen chloride ethanol solution into the beta-hydroxybutyryl-lysine pseudo-dipeptide sodium salt, filtering and concentrating to obtain the beta-hydroxybutyryl-lysine pseudo dipeptide, as a white solid. Nuclear magnetic data for β -hydroxybutyryl-lysine pseudodipeptide: 1HNMR (400MHz, D)2O)δ4.02(m,1H),3.62(m,1H),3.02(m,2H),2.27(m,2H),1.61(m,2H),1.30(m,2H),1.25(m,2H),1.13(m,3H)。
Example 2
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 2.4g of silver nitrate and 2.8g of peptoid compound into 60mL of ethanol water solution, adding 2.8g of reducing agent glucose, and stirring for 50min to uniformly mix the solution to obtain a mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 160 ℃, keeping the temperature for 480 minutes at a constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of the ethanol to the water in the ethanol aqueous solution is 1: 1.
Wherein, the peptoid compound is beta-hydroxybutyryl-glutamic acid pseudo dipeptide, and the structural formula is as follows:
specifically, the method for preparing the β -hydroxybutyryl-glutamic acid pseudodipeptide can be referred to the method for preparing the β -hydroxybutyryl-lysine pseudodipeptide in example 1, and specifically, the β -hydroxybutyryl-lysine pseudodipeptide is prepared from tert-butyldimethylsiloxane β -hydroxybutyric acid and glutamic acid ethyl ester hydrochloride. The nuclear magnetic hydrogen spectrum data of the beta-hydroxybutyryl-glutamic acid pseudo dipeptide is as follows:1H NMR(400MHz,D2O)δ4.23(m,1H),4.15(m,1H),2.49(m,2H),2.25(m,2H),2.09(m,1H),1.92(m,1H),1.26(d,3H)。
example 3
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 0.6g of silver sulfate and 1.8g of peptoid compound into 60mL of acetone aqueous solution, adding 1.2g of reducing agent ascorbic acid, and stirring for 100min to uniformly mix the solution to obtain a mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 200 ℃, keeping the temperature for 600 minutes at a constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of acetone to water in the acetone aqueous solution is 1: 1.
Wherein, the peptoid compound is beta-hydroxybutyryl-glycine-methionine pseudo tripeptide, and the structural formula is as follows:specifically, the preparation method of the β -hydroxybutyryl-glycine-methionine pseudo-tripeptide can be referred to in example 1The preparation method of beta-hydroxybutyryl-lysine pseudo dipeptide is specifically characterized by preparing tert-butyl dimethyl silyl ether beta-hydroxybutyric acid, glycine ethyl ester hydrochloride and methionine ethyl ester hydrochloride. The prepared beta-hydroxybutyryl-glycine-methionine pseudo-tripeptide nuclear magnetic spectrum data are as follows:1H NMR(400MHz,D2O)δ4.21(m,1H),4.07(m,1H),3.84(m,2H),2.35(m,4H),2.00(m,1H),1.98(s,3H),1.80(m,1H),1.13(d,3H)。
example 4
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 0.6g of silver chlorate and 1.8g of peptoid compound into 60mL of acetone aqueous solution, adding 2.0g of reducing agent formaldehyde solution, and stirring for 100min to uniformly mix the solution to obtain a mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 180 ℃, keeping the temperature for 600 minutes at a constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of acetone to water in the acetone aqueous solution is 1: 1.
Wherein, the peptoid compound is beta-hydroxybutyryl-glycine-isoleucine pseudo tripeptide, and the structural formula is as follows:
specifically, the β -hydroxybutyryl-glycine-isoleucine pseudo-tripeptide may be prepared from tert-butyldimethylsiloxane β -hydroxybutyric acid, glycine ethyl ester hydrochloride, and isoleucine ethyl ester hydrochloride, with reference to the method for preparing β -hydroxybutyryl-lysine pseudo-dipeptide in example 1. The prepared beta-hydroxybutyryl-glycine-isoleucine pseudo-tripeptide nuclear magnetic spectrum data are as follows:1H NMR(400MHz,D2O)δ4.21(m,1H),4.07(m,1H),3.84(m,2H),2.35(m,4H),2.00(m,1H),1.98(s,3H),1.80(m,1H),1.13(d,3H)。
example 5
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 2.6g of silver nitrate and 1.8g of peptoid compound into 60mL of glycerol aqueous solution, adding 2.0g of reducing agent sodium borohydride, and stirring for 100min to uniformly mix the solution to obtain a mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 160 ℃, keeping the temperature for 480 minutes at a constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of glycerol to water in the glycerol aqueous solution is 1: 1.
Wherein, the peptoid compound is beta-hydroxybutyryl-glycyl-alanyl-methionine pseudo tetrapeptide, and the structural formula is as follows:
specifically, the β -hydroxybutyryl-glycyl-alanyl-methionine pseudo tetrapeptide is prepared from t-butyldimethylsilyl ether β -hydroxybutyric acid, glycine ethyl ester hydrochloride, alanine ethyl ester hydrochloride and methionine ethyl ester hydrochloride, as described in example 1. The nuclear magnetic hydrogen spectrum data of the prepared beta-hydroxybutyryl-glycyl-alanyl-methionine pseudo tetrapeptide are as follows:1H NMR(400MHz,D2O)δ4.31(m,1H),4.22(m,1H),4.12(m,1H),3.84(m,2H),2.57(m,2H),2.37(m,2H),2.05(s,3H),1.95(m,2H),1.32(d,3H)。
example 6
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 1.6g of silver nitrate and 0.8g of peptoid compound into 60mL of ethylene glycol aqueous solution, adding 2.4g of reducing agent formic acid, and stirring for 100min to uniformly mix the solution to obtain mixed solution; and (3) placing the prepared mixed solution in a crystallization kettle, heating to 150 ℃, keeping the temperature for 660 minutes, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of the ethylene glycol to the water in the ethylene glycol aqueous solution is 1: 1.
Wherein, the peptoid compound is beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide, and the structural formula is as follows:
specifically, the β -hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide can be prepared from β -hydroxybutyryl-lysine pseudodipeptide in example 1, specifically, tert-butyldimethylsiloxane β -hydroxybutyric acid, leucine ethyl ester hydrochloride, valine ethyl ester hydrochloride, and glutamic acid ethyl ester hydrochloride. The nuclear magnetic hydrogen spectrum data of the prepared beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudo tetrapeptide are as follows:1H NMR(400MHz,D2O)δ4.25(m,2H),4.06(m,1H),3.94(m,1H),2.51(m,2H),2.35(m,2H),2.11(m,2H),1.98(m,1H),1.52(m,3H),1.11(d,3H),0.76(m,12H)。
the results of testing the surface morphology of the micro-nano silver powder prepared in the above embodiments 1 to 6 are shown in fig. 1 to 6, respectively.
As can be seen from fig. 1 to 6, the micro-nano silver powder prepared in different embodiments is uniform in distribution and good in dispersibility, and the micro-nano silver powder prepared in different embodiments has different particle sizes and surface forms. Specifically, as can be seen from fig. 1, the micro-nano silver powder prepared in example 1 is granular, and the average particle size is 58-100 nm. As can be seen from FIG. 2, the micro-nano silver powder prepared in example 2 is flaky, and the average particle size is 2-5 μm. As can be seen from FIG. 3, the micro-nano silver powder prepared in example 3 is flaky, and the average particle size is 2-20 μm. As can be seen from FIG. 4, the micro-nano silver powder prepared in example 3 is granular, and the average particle size is between 0.3 and 0.7 μm. As can be seen from FIG. 5, the micro-nano silver powder prepared in example 5 is granular, and the average particle size is between 0.3 and 0.5 μm. As can be seen from FIG. 6, the micro-nano silver powder prepared in example 6 is granular, and the average particle size is between 90 nm and 220 nm.
The specific surface areas and the resistivities of the micro-nano silver powder prepared in the above examples 1 to 6 and the micro-nano silver powder sold in the market are tested, and the results are shown in the following table 1. Wherein, the specific surface area adopts a BET specific surface area test method, and the resistivity test method comprises the following steps: an ST2742B type automatic powder resistivity tester manufactured by Suzhou crystal lattice electronics Limited is adopted, and the listed data are resistivity data of a sample to be tested under 28-30 MPa.
TABLE 1 specific surface area and resistivity data for different samples
As can be seen from the above table 1, the specific surface area of the micro-nano silver powder prepared by the method is smaller than that of a commercially available sample with the same morphology, and the resistivity of the micro-nano silver powder is obviously smaller than that of the commercially available sample with the same morphology.
The micro-nano silver powder prepared in the embodiment 2 and a commercially available sample with the same shape as the embodiment 2 are further used for preparing the photovoltaic heterojunction conductive silver paste. The preparation method comprises the following steps: and (3) uniformly mixing the organic system, adding the micro-nano silver powder or the commercially available sample prepared in the embodiment 2, uniformly mixing the micro-nano silver powder or the commercially available sample through a planetary gravity mixer, and finally mixing the micro-nano silver powder or the commercially available sample through a three-roll machine to obtain the photovoltaic heterojunction conductive silver paste. Wherein the organic system comprises: the adhesive comprises an adhesive phase, a solvent and an auxiliary agent, wherein the adhesive phase comprises a mixture of bisphenol A epoxy resin and bisphenol F epoxy resin, the solvent is a DBE dibasic acid ester mixture, and the auxiliary agent comprises a mixture of a defoaming agent, a thixotropic agent, a lubricant and a curing agent.
The conductive silver paste prepared by the method has the viscosity of 28-30 ten thousand cps tested by a Bohler flying viscometer.
156 × 156 heterojunction battery pieces are selected, the micro-nano silver powder in the embodiment 2 and the conductive silver paste prepared by the method according to the embodiment 2 are used for preparing the battery pieces through the processes of screen printing, curing, light injection and the like, the open circuit voltage Uoc, the short circuit current Isc, the filling factor FF, the conversion efficiency Eta and the resistance value Rser are tested, and the results are shown in the following table 2.
Table 2-properties of the cell sheets prepared from different conductive silver pastes
Battery piece | Uoc(V) | Isc(A) | FF(%) | Eta(%) | Rser(Ohm) |
Battery piece 1 | 0.7494 | 9.3435 | 84.02 | 24.023 | 0.0025 |
Battery piece 2 | 0.7494 | 9.3459 | 83.24 | 23.676 | 0.0033 |
In table 2, the cell piece 1 is a cell piece prepared from the low-temperature conductive silver paste prepared from the micro-nano silver powder in the above example 2, and the cell piece 1 is a cell piece prepared from the low-temperature conductive silver paste prepared from a commercially available sample with the same shape and appearance as those in the example 2. It can be seen from table 2 that the battery piece 1 has better performance, and thus, the conductive silver paste prepared from the micro-nano silver powder prepared in the application has better performance than the conductive silver paste prepared from silver powder on the market at home.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (8)
1. A preparation method of micro-nano silver powder is characterized by comprising the following steps:
dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder; wherein the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
2. The method for preparing micro-nano silver powder according to claim 1, wherein the silver salt comprises at least one of silver nitrate, silver sulfate and silver halide.
3. The method for preparing micro-nano silver powder according to claim 1, wherein the solvent comprises one of water, methanol, ethanol, ethylene glycol, glycerol and acetone.
4. The method for preparing micro-nano silver powder according to claim 1, wherein the reducing agent comprises at least one of glucose, formaldehyde, formic acid, ethylene glycol, sodium borohydride and ascorbic acid.
5. The method for preparing micro-nano silver powder according to claim 1, wherein the micro-nano silver powder is obtained by dissolving a peptoid compound in a solvent, adding a silver salt and a reducing agent, reacting, and filtering, wherein the reaction temperature is 80-220 ℃ and the reaction time is 180-720 min.
6. The method for preparing micro-nano silver powder according to claim 1, wherein the mass-to-volume ratio of the peptoid compound, the silver salt, the reducing agent and the solvent is (0.5-10) g, (0.5-15) g, (0.5-18) g, (30-80) ml.
7. The micro-nano silver powder is characterized by being prepared by the preparation method according to any one of claims 1 to 6.
8. The application of the micro-nano silver powder of claim 7 in preparing conductive silver paste, electronic ceramics, bactericidal disinfectant and solar photovoltaic power generation devices.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549513.8A CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549513.8A CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113275584A true CN113275584A (en) | 2021-08-20 |
CN113275584B CN113275584B (en) | 2023-11-14 |
Family
ID=77280222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110549513.8A Active CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113275584B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115780821A (en) * | 2022-11-28 | 2023-03-14 | 苏州银瑞光电材料科技有限公司 | Preparation method of flake silver powder with high tap density |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586774A (en) * | 2004-07-06 | 2005-03-02 | 中国乐凯胶片集团公司 | Process for preparing nano silver colloidal water solution |
KR20090073929A (en) * | 2007-12-31 | 2009-07-03 | 주식회사 휘닉스피디이 | Method of manufacturing silver powder |
JP2009221598A (en) * | 2008-01-17 | 2009-10-01 | Mitsubishi Materials Corp | Method for synthesizing metal nanoparticle |
CN102120265A (en) * | 2010-01-07 | 2011-07-13 | 中国科学院化学研究所 | Preparation method of colloid of mono-dispersed silver nano particles and nano silver powder and conductive ink thereof |
US20110230427A1 (en) * | 2010-03-22 | 2011-09-22 | David Bruce Robinson | Materials and methods for stabilizing nanoparticles in salt solutions |
CN103302305A (en) * | 2013-06-09 | 2013-09-18 | 佛山市天宝利太阳能科技有限公司 | Method for preparing silver nanowires by using biomolecular amino acid as reducing agent |
KR101484743B1 (en) * | 2013-08-13 | 2015-01-26 | 고려대학교 산학협력단 | Preparation method of metal nanostructures based on biomolecules |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN108015299A (en) * | 2017-11-06 | 2018-05-11 | 珠海纳金科技有限公司 | Nano-Ag particles and preparation method thereof |
US20190039142A1 (en) * | 2016-05-04 | 2019-02-07 | Suzhou Smart Advanced Coating Technologies Co., Ltd. | A method for preparing silver powder by using micro-nano bubbles as crystal seeds |
WO2019088509A1 (en) * | 2017-10-31 | 2019-05-09 | 엘에스니꼬동제련 주식회사 | Surface-treated silver powder and preparation method therefor |
CN110303168A (en) * | 2019-08-06 | 2019-10-08 | 郴州市金贵银业股份有限公司 | A kind of preparation method of nano-silver powder |
-
2021
- 2021-05-20 CN CN202110549513.8A patent/CN113275584B/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586774A (en) * | 2004-07-06 | 2005-03-02 | 中国乐凯胶片集团公司 | Process for preparing nano silver colloidal water solution |
KR20090073929A (en) * | 2007-12-31 | 2009-07-03 | 주식회사 휘닉스피디이 | Method of manufacturing silver powder |
JP2009221598A (en) * | 2008-01-17 | 2009-10-01 | Mitsubishi Materials Corp | Method for synthesizing metal nanoparticle |
CN102120265A (en) * | 2010-01-07 | 2011-07-13 | 中国科学院化学研究所 | Preparation method of colloid of mono-dispersed silver nano particles and nano silver powder and conductive ink thereof |
US20110230427A1 (en) * | 2010-03-22 | 2011-09-22 | David Bruce Robinson | Materials and methods for stabilizing nanoparticles in salt solutions |
CN103302305A (en) * | 2013-06-09 | 2013-09-18 | 佛山市天宝利太阳能科技有限公司 | Method for preparing silver nanowires by using biomolecular amino acid as reducing agent |
KR101484743B1 (en) * | 2013-08-13 | 2015-01-26 | 고려대학교 산학협력단 | Preparation method of metal nanostructures based on biomolecules |
US20190039142A1 (en) * | 2016-05-04 | 2019-02-07 | Suzhou Smart Advanced Coating Technologies Co., Ltd. | A method for preparing silver powder by using micro-nano bubbles as crystal seeds |
WO2019088509A1 (en) * | 2017-10-31 | 2019-05-09 | 엘에스니꼬동제련 주식회사 | Surface-treated silver powder and preparation method therefor |
CN108015299A (en) * | 2017-11-06 | 2018-05-11 | 珠海纳金科技有限公司 | Nano-Ag particles and preparation method thereof |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN110303168A (en) * | 2019-08-06 | 2019-10-08 | 郴州市金贵银业股份有限公司 | A kind of preparation method of nano-silver powder |
Non-Patent Citations (4)
Title |
---|
HAGAR TIGGER-ZABOROV等: "Aggregation of Ag(0) nanoparticles to unexpected stable chain-like assemblies mediated by 2, 20 -bipyridine decorated peptoids", JOURNAL OF COLLOID AND INTERFACE SCIENCE, vol. 533, pages 598 - 603, XP085497314, DOI: 10.1016/j.jcis.2018.08.094 * |
余家会等: "基因与纳米探针:医学分子成像理论与实践", 天津科学技术出版社, pages: 625 - 626 * |
田晓霞;张武森;赵云飞;司丹丹;胡军洲;: "化学还原法制备不同形貌的纳米银粉", 信息记录材料, no. 04, pages 625 - 626 * |
黄仁亮;齐崴;姜楠;苏荣欣;何志敏;: "肽基纳米材料及其应用", 化学进展, no. 12, pages 2328 - 2337 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115780821A (en) * | 2022-11-28 | 2023-03-14 | 苏州银瑞光电材料科技有限公司 | Preparation method of flake silver powder with high tap density |
CN115780821B (en) * | 2022-11-28 | 2024-06-11 | 苏州银瑞光电材料科技有限公司 | Preparation method of high tap density flake silver powder |
Also Published As
Publication number | Publication date |
---|---|
CN113275584B (en) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101770869B (en) | Method for preparing titanium dioxide films for dye-sensitized solar battery | |
CN113275584B (en) | Micro-nano silver powder and preparation method and application thereof | |
CN109794264B (en) | Micro-popcorn-shaped high-performance full-hydrolysis bifunctional electrocatalyst FeOOH/Ni3S2Preparation method of (1) | |
KR20110058307A (en) | Conductive ink composition which does not form a particle and preparation thereof | |
CN101318703A (en) | Tungstic oxide nano-wire and method for preparing tungstic oxide nano-wire ammonia sensitive sensor | |
CN108866561A (en) | A kind of preparation method and applications of electro-catalysis carbon dioxide reduction electrode | |
CN108565041A (en) | A kind of high conductance proper alignment type low temperature silver paste and preparation method thereof | |
CN106082184B (en) | A kind of nitrogen sulphur codope graphene and preparation method and application | |
CN109485085B (en) | A kind of preparation method of hollow octahedra cuprous oxide | |
CN106732613A (en) | A kind of preparation method of novel nano carbon material and its electro-catalysis hydrogen manufacturing application | |
CN110746631A (en) | Solar photo-thermal conversion composite film and preparation method thereof | |
CN108878158A (en) | A kind of preparation method and purposes of C-base composte material | |
TWI428285B (en) | Micro-scaled flake silver particles and method for producing the same | |
Zhu et al. | Elimination of defect and strain by functionalized CQDs dual-engineering for all-inorganic HTMs-free perovskite solar cells with an ultrahigh voltage of 1.651 V | |
CN106206951A (en) | The new application of polyvinylamine, perovskite thin film, perovskite solaode and preparation method thereof | |
CN109603832A (en) | A kind of method of a large amount of flower-shaped cobalt-based double-metal hydroxide of quick preparation | |
CN115178747A (en) | Efficient preparation method of high-crystallinity silver powder | |
CN107413367B (en) | High-dispersion cobalt ferrite nanoparticle loaded oxa-carbon nitride and preparation method thereof | |
CN106064828A (en) | Solid phase method prepares the method for Zinc oxide powder | |
CN112675836B (en) | Platinum nanoparticle/carbon nitride/bismuth oxybromide composite material, sensitized photoelectrochemical sensor and preparation method and application thereof | |
CN108372310A (en) | A kind of preparation method of small-size nano-silver for water-base conductive ink | |
CN110241439A (en) | A kind of corona treatment prepares surface hydroxylation WO3The method of film photoelectric electrode material | |
JP2010077520A (en) | Method for producing fine copper particle, and fine copper particle | |
CN109926070B (en) | Mn (manganese)0.5Cd0.5S/WO3Preparation method of Au supported photocatalyst | |
CN111014716A (en) | Method for macroscopic preparation of AIE copper nanoclusters by cysteamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240105 Address after: No. 3 North Xinzhuang Village Street, Wulongkou Town, Jiyuan City, Henan Province, 459000 Patentee after: Jiyuan Xinghan New Materials Technology Co.,Ltd. Address before: 215200 east side of Chang'an Road, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou Xinghan New Material Technology Co.,Ltd. |